Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma von Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O’Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Attal, Michel, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Chiu, Christopher, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Kobos, Rachel, Qi, Ming, Usmani, Saad Z

Volltext

Les nouveaux médicaments du myélome von Hulin, C.

Volltext

Minor clone provides a reservoir for relapse in multiple myeloma von Magrangeas, F, Avet-Loiseau, H, Gouraud, W, Lodé, L, Decaux, O, Godmer, P, Garderet, L, Voillat, L, Facon, T, Stoppa, A M, Marit, G, Hulin, C, Casassus, P, Tiab, M, Voog, E, Randriamalala, E, Anderson, K C, Moreau, P, Munshi, N C, Minvielle, S

Volltext

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study von Macro, M., Hulin, C., Vincent, L., Charvet-Rumpler, A., Benboubker, L., Calmettes, C., Stoppa, A.-M., Laribi, K., Clement-Filliatre, L., Zerazhi, H., Honeyman, F., Richez, V., Maloisel, F., Karlin, L., Barrak, J., Chouaid, C., Leleu, X.

Volltext

O69 Les marqueurs rénaux utilisés conjointement sont des marqueurs de risques cardiovasculaire et non cardiovasculaire majeurs chez les diabétiques de type 2 von Monseu, M, Gand, E, Saulnier, P.-J, Montaigne, D, Zaoui, P, Rigalleau, V, Ducroq, G, Roussel, R, Hulin, C, Sosner, P, Llaty, P, Ragot, S, Hadjadj, S, Halimi, J.-M

Volltext

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients von Hebraud, B, Leleu, X, Lauwers-Cances, V, Roussel, M, Caillot, D, Marit, G, Karlin, L, Hulin, C, Gentil, C, Guilhot, F, Garderet, L, Lamy, T, Brechignac, S, Pegourie, B, Jaubert, J, Dib, M, Stoppa, A-M, Sebban, C, Fohrer, C, Fontan, J, Fruchart, C, Macro, M, Orsini-Piocelle, F, Lepeu, G, Sohn, C, Corre, J, Facon, T, Moreau, P, Attal, M, Avet-Loiseau, H

Volltext

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone von Avet-Loiseau, H, Soulier, J, Fermand, J-P, Yakoub-Agha, I, Attal, M, Hulin, C, Garderet, L, Belhadj, K, Dorvaux, V, Minvielle, S, Moreau, P

Volltext

Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials von Palumbo, Antonio, Waage, Anders, Hulin, Cyrille, Beksac, Meral, Zweegman, Sonja, Gay, Francesca, Gimsing, Peter, Leleu, Xavier, Wijermans, Pierre, Sucak, Gülsan, Pezzatti, Sara, Juliusson, Gunnar, Pégourié, Brigitte, Schaafsma, Martijn, Galli, Monica, Turesson, Ingemar, Kolb, Brigitte, van der Holt, Bronno, Baldi, Ileana, Rolke, Jürgen, Ciccone, Giovannino, Wetterwald, Marc, Lokhorst, Henk, Boccadoro, Mario, Rodon, Philippe, Sonneveld, Pieter

Volltext

Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort von Chalopin, T., Macro, M., Decaux, O., Royer, B., Gounot, R., Bobin, A., Karlin, L., Mohty, M., Frenzel, L., Perrot, A., Manier, S., Vincent, L., Dib, M., Slama, B., Richez, V., Allangba, O., Zunic, P., Newinger-Porte, M., Mariette, C., Joly, B., Gay, J., Botoc, I., Malfuson, JV, Garlantezec, R., Hulin, C.

Volltext

Antecedents and Consequences of Sexual Harassment in Organizations: A Test of an Integrated Model von Fitzgerald, Louise F, Drasgow, Fritz, Hulin, Charles L, Gelfand, Michele J, Magley, Vicki J

Volltext

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience von Avet-Loiseau, H, Roussel, M, Campion, L, Leleu, X, Marit, G, Jardel, H, Dib, M, Decaux, O, Lamy, T, Tiab, M, Cony-Makhoul, P, Banos, A, Lepeu, G, Lifermann, F, Macro, M, Kolb, B, Hulin, C, Caillot, D, Traulle, C, Mathiot, C, Royer, B

Volltext

Treating an elderly with multiple myeloma von Hulin, C

Volltext

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial von KROPFF, Martin, GIONGCO BAYLON, Honorata, AVET-LOISEAU, Herve, MOEHLER, Thomas M, PATTOU, Claire, LUCY, Lela, KUEENBURG, Elisabeth, GLASMACHER, Axel, ZERBIB, Robert, FACON, Thierry, HILLENGASS, Jens, ROBAK, Tadeusz, HAJEK, Roman, LIEBISCH, Peter, GORANOV, Stefan, HULIN, Cyrille, BLADE, Joan, CARAVITA, Tommaso

Volltext

IVA.1 Multiple myeloma (MM) after age 80 von Hulin, C

Volltext

Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed... von Moreau, P, Cavallo, F, Leleu, X, Hulin, C, Amiot, M, Descamps, G, Facon, T, Boccadoro, M, Mignard, D, Harousseau, J L

Volltext

Outcomes of Self-Labeling Sexual Harassment von Magley, Vicki J, Hulin, Charles L, Fitzgerald, Louise F, DeNardo, Mary

Volltext

P30 SINGLE COHORT RESULTS FROM MAJESTEC‐2: TECLISTAMAB (TEC) IN COMBINATION WITH SUBCUTANEOUS DARATUMUMAB (DARA) AND LENALIDOMIDE (LEN) IN PATIENTS WITH MULTIPLE MYELOMA (MM) von Searle, E., Quach, H., Wong, S., Costa, L., Hulin, C., Janowski, W., Berdeja, J., Anguille, S., Matous, J., Touzeau, C., Michallet, A., Husnik, M., Vishwamitra, D., Niu, Z., Larsen, J., Chen, L., Goldberg, J., Popat, R., Spencer, A.

Volltext

S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASONE AS INDUCTION THERAPY IN HIGH‐RISK TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: RESULTS OF THE PHASE 2 STUDY IF... von Touzeau, C., Perrrot, A., Hulin, C., Manier, S., Macro, M., Chretien, M.‐L., Karlin, L., Decaux, O., Jacquet, C., Tiab, M., Leleu, X., Planchce, L., Avet‐Loiseau, H., Moreau, P.

Volltext

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis von McCarthy, Philip L, Holstein, Sarah A, Petrucci, Maria Teresa, Richardson, Paul G, Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C, Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D, Palumbo, Antonio, Attal, Michel

Volltext

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma von Fouquet, G., Pegourie, B., Macro, M., Petillon, M.O., Karlin, L., Caillot, D., Roussel, M., Arnulf, B., Mathiot, C., Marit, G., Kolb, B., Stoppa, A.M., Brechiniac, S., Richez, V., Rodon, P., Banos, A., Wetterwald, M., Garderet, L., Royer, B., Hulin, C., Benbouker, L., Decaux, O., Escoffre-Barbe, M., Fermand, J.P., Attal, M., Avet-Loiseau, H., Moreau, P., Facon, T., Leleu, X.

Volltext